Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 5-Oil prices close to 13-month highs, supported by Texas cold snap

Tue, 16th Feb 2021 11:32

* Texas cold snap shuts down oil wells and refineries

* Middle East supply worries raised by Yemen conflict

* Norwegian oil terminal wage dispute resolved
(Updates prices, adds UBS price forecast)

By Shadia Nasralla

LONDON, Feb 16 (Reuters) - Oil prices hovered near 13-month
highs on Tuesday, supported by a U.S. cold snap that shut wells
in the oil-producing state of Texas, though gains were capped by
a Norwegian wage deal that averted supply disruptions in Europe.

The global rollout of coronavirus vaccinations, fuelling
expectations of a recovery in the global economy and oil demand,
has also kept prices buoyant.

Keenly watched U.S. oil inventory data from the API industry
association and Energy Information Administration (EIA) will be
released this week on Wednesday and Thursday respectively, each
delayed by a day after U.S. markets were closed for a public
holiday on Monday.

Benchmark Brent crude slipped 37 cents, or 0.5%, to
$62.93 a barrel by 1434 GMT but remained 13-month peak reached
in the previous session.

U.S. West Texas Intermediate (WTI) crude futures
gained 45 cents, or 0.8%, to $59.92 after touching their highest
since early January last year.

Swiss bank UBS increased its Brent price forecast, saying it
expects the benchmark to reach $68 a barrel in the second half
of the year and $70 by March 2022, with WTI trading at a $3
discount.

Cold weather in the United States halted operations at Texas
oil wells and refineries on Monday and forced restrictions on
natural gas and crude pipeline operators.

Texas produces about 4.6 million barrels per day of oil and
is home to 31 refineries, the most of any U.S. state and
including some of the country's largest, EIA data shows.

Middle East supply concerns also rose after the Saudi-led
coalition fighting the Houthi group in Yemen said on Monday that
it had destroyed an explosive-laden drone fired by the Houthis
at the kingdom, the world's biggest oil exporter.

But in a move that helped to cap prices, Norway's oil
industry employers struck a wage deal with the Safe labour union
on Tuesday, preventing a strike at the Mongstad crude terminal,
which could have forced major offshore oil and gas fields to
shut.

(Additional reporting by Jessica Jaganathan in Singapore
Editing by Edmund Blair and David Goodman
)

More News
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.